•
Dec 31, 2023

Allovir Q4 2023 Earnings Report

Total Revenue
$0
EPS
-$0.53
Previous year: -$0.37
+43.2%
Gross Profit
-$141K
Cash and Equivalents
$184M
Previous year: $234M
-21.3%
Free Cash Flow
-$30.7M
Total Assets
$191M
Previous year: $277M
-31.1%

Allovir

Allovir